All In Biotech

Drug Trial Radar · NCT00102375

Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer

Phase III Multicenter Study in Epithelial Ovarian Carcinoma FIGO Stage IIB-IV Comparing Treatment With Paclitaxel and Carboplatin to Paclitaxel and Carboplatin Sequentially Followed by Topotecan

Last checked: Nov 19, 2026Latest source record: Aug 4, 2006 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 900 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

900

Actual

Start

Dec 1999

Primary completion

Not stated

Study completion Oct 2004

Sponsor

Lead sponsor
AGO Study GroupAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 31, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether the triple combination of Carboplatin, Paclitaxel and Topotecan has a superior clinical outcome in the treatment of ovarian cancer compared with the combination of Carboplatin and Paclitaxel.

Conditions

  • Ovarian Cancer

Interventions

  • TopotecanDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Survival

Locations

18 sites in 1 country. Site status is shown where the registry gives one.

  • Gynecologic Hospital of the Medical Facilities RWTH

    Aachen, Germany

  • Clinic for Gynecology and Gyn. Oncology, Humboldt University

    Berlin, Germany

  • University Clinic Carl Gustav Carus, Gynecological hospital

    Dresden, Germany

  • Gynecologic Hospital

    Düsseldorf, Germany

  • University Gynecologic Hospital

    Düsseldorf, Germany

  • University Gynecologic Hospital

    Frankfurt, Germany

  • University Gynecologic Hospital

    Göttingen, Germany

  • Gynecologic Clinic of the Ernst-Moritz-Arndt-University

    Greifswald, Germany

  • Gynecological Clinic of the Medical University

    Hanover, Germany

  • St. Vincentius Gynecologic Hospital

    Karlsruhe, Germany

  • University Clinic Schleswig-Holstein, Campus Kiel, Clinic for gynecology and obstetrics

    Kiel, Germany

  • Otto-von-Guericke University, University Gynecological Hospital

    Magdeburg, Germany

  • University Gynecologic Hospital Grosshadern

    München, Germany

  • University Gynecologic Hospital "rechts der Isar"

    München, Germany

  • Clinic for Gynecology

    Münster, Germany

  • University Gynecologic Hospital

    Tübingen, Germany

  • University Gynecological Hospital

    Ulm, Germany

  • Clinic for Gnyecology and gyn. Oncology HSK

    Wiesbaden, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.